FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved a supplemental application for Pulmicort Respules (budesonide) to update/expand the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Respules (budesonide)

Snippet

SUPPL AP for PULMICORT RESPULES (BUDESONIDE)